Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tri Chemical LaboratoriesFRA:22E -2.34%90 EV-to-EBITDA is 9.58 as of Aug. 31, 2026, which is 34% below its 10-year median of 14.60. GuruFocus rates FRA:22E with a GF Score™ of 90/100 and a GF Value™ of €27.44 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,342 Chemicals companies, Tri Chemical Laboratories ranks better than 59.17% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tri Chemical Laboratories's enterprise value is €538.9 Mil.
Tri Chemical Laboratories's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was €56.2 Mil. Therefore, Tri Chemical Laboratories's EV-to-EBITDA for today is 9.58.
The historical rank and industry rank for Tri Chemical Laboratories's EV-to-EBITDA or its related term are showing as below:
FRA:22E'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.73 Med: 14.6 Max: 33.35
Current: 9.9
During the past 13 years, the highest EV-to-EBITDA of Tri Chemical Laboratories was 33.35. The lowest was 6.73. And the median was 14.60.
FRA:22E's EV-to-EBITDA is ranked better than 59.17% of 1342
companies
in the Chemicals industry
Industry Median: 12.395
vs FRA:22E: 9.90
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Tri Chemical Laboratories (FRA:22E) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Tri Chemical Laboratories's PE Ratio (TTM) for today is calculated as:
Tri Chemical Laboratories's share price for today is €16.70.
Tri Chemical Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.055.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Tri Chemical Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tri Chemical Laboratories EV-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tri Chemical Laboratories's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Tri Chemical Laboratories's EV-to-EBITDA falls into.
Tri Chemical Laboratories's current Enterprise Value is €538.9 Mil.
Tri Chemical Laboratories's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €56.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tri Chemical Laboratories (FRA:22E) has a EV-to-EBITDA of 9.58 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tri Chemical Laboratories. This is 34% below median its historical median of 14.60. Over the past decade, Tri Chemical Laboratories' EV-to-EBITDA has ranged from 6.73 to 33.35. According to the industry distribution chart, Tri Chemical Laboratories ranks #548 out of 1342 companies in the Chemicals industry, placing it in the top 40.8%.
Is Tri Chemical Laboratories' EV-to-EBITDA too high?
Tri Chemical Laboratories' current EV-to-EBITDA of 9.58 is 34% below median its 10-year median of 14.60. Over the past 10 years, this metric has ranged from a low of 6.73 to a high of 33.35. The Chemicals industry median EV-to-EBITDA is 12.40. Tri Chemical Laboratories' value of 9.58 is 22.7% below this industry median. Based on the distribution chart, Tri Chemical Laboratories ranks #548 out of 1342 companies in the Chemicals industry, which is above the industry midpoint. Overall, Tri Chemical Laboratories has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tri Chemical Laboratories' EV-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tri Chemical Laboratories ranks #548 out of 1342 companies for EV-to-EBITDA. This puts Tri Chemical Laboratories in the upper half of its industry. The industry median EV-to-EBITDA is 12.40. Tri Chemical Laboratories' value of 9.58 is 22.7% below this benchmark. Historically, Tri Chemical Laboratories' own EV-to-EBITDA has ranged from 6.73 to 33.35 over the past decade. While the company's 10-year median is 14.60 vs. the industry median of 12.40, Tri Chemical Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Chemicals company?
The median EV-to-EBITDA among Chemicals companies is 12.40, based on 1,342 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tri Chemical Laboratories's current EV-to-EBITDA of 9.58 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tri Chemical Laboratories. For the Chemicals industry, the median EV-to-EBITDA is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tri Chemical Laboratories's current EV-to-EBITDA is 9.58, which is 34% below median its own 10-year median of 14.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tri Chemical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Tri Chemical Laboratories (FRA:22E) is currently considered Significantly Undervalued. The stock's GF Value™ is €27.44, compared to a current price of €16.70 — trading 39.1% below its estimated fair value. The current EV-to-EBITDA is 9.58, which is 34% below median its 10-year median of 14.60 and 22.7% below the Chemicals industry median of 12.40. Tri Chemical Laboratories' overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Tri Chemical Laboratories (FRA:22E), the current EV-to-EBITDA is 9.58 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tri Chemical Laboratories (FRA:22E) Overvalued in 2026?
Based on GuruFocus' analysis, Tri Chemical Laboratories stock appears to be undervalued.
The current stock price of €16.70 is trading 39.1% below its estimated GF Value™ of €27.44.
GuruFocus considers Tri Chemical Laboratories to be Significantly Undervalued.
Key valuation signals for FRA:22E:
EV-to-EBITDA: 9.58 (34% below median its 10-year median of 14.60)
GF Value™: €27.44 vs. price of €16.70 (39.1% below fair value)
Industry Position: 22.7% below the Chemicals median (#548 of 1342)
No single metric tells the full story. See the FRA:22E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:22E has been successfully added to your 
